| The role of tumor microenvironment in chemoresistance: to survive, keep your enemies closer DA Senthebane, A Rowe, NE Thomford, H Shipanga, D Munro, ... International journal of molecular sciences 18 (7), 1586, 2017 | 391 | 2017 |
| Advances in regenerative medicine and tissue engineering: innovation and transformation of medicine K Dzobo, NE Thomford, DA Senthebane, H Shipanga, A Rowe, ... Stem cells international 2018, 2018 | 374 | 2018 |
| Genetic polymorphism of CYP2D6 and CYP2C19 in east-and southern African populations including psychiatric patients C Dandara, C Mutowembwa Masimirembwa, A Magimba, J Sayi, S Kaaya, ... European journal of clinical pharmacology 57, 11-17, 2001 | 130 | 2001 |
| Pharmacogenomics implications of using herbal medicinal plants on African populations in health transition NE Thomford, K Dzobo, D Chopera, A Wonkam, M Skelton, D Blackhurst, ... Pharmaceuticals 8 (3), 637-663, 2015 | 123 | 2015 |
| The role of tumor microenvironment in chemoresistance: 3D extracellular matrices as accomplices DA Senthebane, T Jonker, A Rowe, NE Thomford, D Munro, C Dandara, ... International journal of molecular sciences 19 (10), 2861, 2018 | 119 | 2018 |
| Effect of rifampicin-based antitubercular therapy and the cytochrome P450 2B6 516G> T polymorphism on efavirenz concentrations in adults in South Africa K Cohen, A Grant, C Dandara, H McIlleron, L Pemba, K Fielding, ... Antiviral therapy 14 (5), 687-695, 2009 | 116 | 2009 |
| The African‐specific CYP2D6*17 allele encodes an enzyme with changed substrate specificity A Wennerholm, C Dandara, J Sayi, JO Svensson, YA Abdi, ... Clinical Pharmacology & Therapeutics 71 (1), 77-88, 2002 | 107 | 2002 |
| Singapore COVID-19 pandemic response as a successful model framework for low-resource health care settings in Africa? O Kuguyo, AP Kengne, C Dandara Omics: a journal of integrative biology 24 (8), 470-478, 2020 | 100 | 2020 |
| Advances in therapeutic targeting of cancer stem cells within the tumor microenvironment: an updated review K Dzobo, DA Senthebane, C Ganz, NE Thomford, A Wonkam, C Dandara Cells 9 (8), 1896, 2020 | 94 | 2020 |
| Pharmacogenomic research in South Africa: lessons learned and future opportunities in the rainbow nation L Warnich, B I Drogemoller, M S Pepper, C Dandara, G EB Wright Current Pharmacogenomics and Personalized Medicine (Formerly Current …, 2011 | 90 | 2011 |
| High predictive value of CYP2B6 SNPs for steady-state plasma efavirenz levels in South African HIV/AIDS patients M Swart, M Skelton, Y Ren, P Smith, S Takuva, C Dandara Pharmacogenetics and Genomics 23 (8), 415-427, 2013 | 80 | 2013 |
| CYP3A5 genotypes and risk of oesophageal cancer in two South African populations C Dandara, R Ballo, MI Parker Cancer letters 225 (2), 275-282, 2005 | 80 | 2005 |
| Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity C Dandara, Z Lombard, I Du Plooy, T McLellan, SA Norris, M Ramsay Pharmacogenomics 12 (12), 1663-1670, 2011 | 79 | 2011 |
| The 341C/T polymorphism in the GSTP1 gene is associated with increased risk of oesophageal cancer D Li, C Dandara, MI Parker BMC genetics 11, 1-9, 2010 | 74 | 2010 |
| Genetic polymorphism of cytochrome P450 1A1 (Cyp1A1) and glutathione transferases (M1, T1 and P1) among Africans C Dandara, J Sayi, C M. Masimirembwa, A Magimba, S Kaaya, ... Walter de Gruyter 40 (9), 952-957, 2002 | 72 | 2002 |
| Gene–environment interaction: the role of SULT1A1 and CYP3A5 polymorphisms as risk modifiers for squamous cell carcinoma of the oesophagus C Dandara, DP Li, G Walther, MI Parker Carcinogenesis 27 (4), 791-797, 2006 | 71 | 2006 |
| Cervical cancer in Zimbabwe: a situation analysis O Kuguyo, A Matimba, N Tsikai, T Magwali, M Madziyire, M Gidiri, ... The Pan African Medical Journal 27, 2017 | 70 | 2017 |
| ABCB1 4036A> G and 1236C> T polymorphisms affect plasma efavirenz levels in South African HIV/AIDS patients M Swart, Y Ren, P Smith, C Dandara Frontiers in genetics 3, 36057, 2012 | 67 | 2012 |
| Cancer stem cell hypothesis for therapeutic innovation in clinical oncology? Taking the root out, not chopping the leaf K Dzobo, DA Senthebane, A Rowe, NE Thomford, LM Mwapagha, ... Omics: a journal of integrative biology 20 (12), 681-691, 2016 | 66 | 2016 |
| Fibroblast-derived extracellular matrix induces chondrogenic differentiation in human adipose-derived mesenchymal stromal/stem cells in vitro K Dzobo, T Turnley, A Wishart, A Rowe, K Kallmeyer, FA Van Vollenstee, ... International journal of molecular sciences 17 (8), 1259, 2016 | 66 | 2016 |
Prof Ambroise Wonkam, MD, DMedSc,...Division of Human Genetics - Faculty of Health Sciences - University of Cape Town - South AfricaVerified email at uct.ac.za
